DISQUS

Raj Nihalani, MD, RAC(US) · 1 year ago

A)Cuting the the overall size of the deal by 15 percent is one of the signs of disengagement
B)A big elephant like Oracle in this case does not get hurt in this deal.
C)External market events trigger provisions that made the acquisition untenable
It the cocktail of events that make or break the deals.
I feel this deal is a bust!

Raj Nihalani, MD, RAC(US)
Irvine
David P. Hamilton · 1 year ago

I think (a) and (c) are absolutely correct. On (b), I'd only note that the SPAC Oracle Healthcare appears to be unrelated to Oracle the software company. SPACs are odd "blank check" companies designed specifically for acquisitions; in this case, I don't think the name shared with Larry Ellison's outfit actually means anything.
Terry2009 · 4 months ago

I think it's important to note that the activities of Precision Therapeutics have garnered more negative attention, as noted in this article: A Pittsburgh-based high-tech firm developing cancer diagnostic tests may have violated federal rules governing human subjects research by failing to obtain proper informed consent from participants in a key study...
http://www.tradingmarkets.com/.site/news/Stock%...